Skip to main content

Dravet Syndrome clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for
  • Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome

    Sorry, not currently recruiting here

    The primary purpose of the study is to demonstrate that lorcaserin has superior efficacy compared to placebo on percent change in frequency of convulsive seizures per 28 days in participants with Dravet syndrome.

    San Diego, California and other locations

Last updated: